Home/Filings/4/0001104659-21-144009
4//SEC Filing

Lamstein Joshua R 4

Accession 0001104659-21-144009

CIK 0001772028other

Filed

Nov 25, 7:00 PM ET

Accepted

Nov 26, 5:01 PM ET

Size

5.9 KB

Accession

0001104659-21-144009

Insider Transaction Report

Form 4
Period: 2021-11-23
Lamstein Joshua R
DirectorChairman
Transactions
  • Other

    W Warrants

    2021-11-233,000,0000 total(indirect: By LLC)
    Exercise: $4.00From: 2021-10-01Exp: 2026-09-30B Unit (3,000,000 underlying)
Footnotes (1)
  • [F1]The Reporting Person is a member and co-manager of HCFP/Capital Partners 18B-2 LLC ("HCFP 18B-2"). On November 23, 2021, HCFP 18B-2, pursuant to a Warrant Contribution Agreement by and between the Issuer and HCFP 18B-2, agreed to contribute its 3,000,000 W Warrants back to the Company in exchange for the Company cancelling a $1.5 million contingent promissory note, including any and all interest, owed by HCFP 18B-2 to the Company.

Issuer

Scopus BioPharma Inc.

CIK 0001772028

Entity typeother

Related Parties

1
  • filerCIK 0001665280

Filing Metadata

Form type
4
Filed
Nov 25, 7:00 PM ET
Accepted
Nov 26, 5:01 PM ET
Size
5.9 KB